Document Title
ACP Letter to House Sponsors of the Patient Protection and Affordable Care Enhancement Act (H.R. 1425)
Synopsis
Letter to House Sponsors of the Patient Protection and Affordable Care Enhancement Act (H.R. 1425) in support of the ACA and offering ACP's positions on the policies of H.R. 1425.
Author
Jonni McCrann
Keywords
Affordable Care Act, ACA, Patient Protection and Affordable Care Enhancement Act, HR 1425, health coverage, pre-existing conditions, prescription drugs, consumer protections, essential benefits, quality of care, coronavirus, COVID-19, health insurance marketplace, Medicaid, health insurance affordability fund, reinsurance, market stabilization, short-term limited duration health plans, FMAP, premiums, cost-sharing, mandatory work requirements, Medicaid pay parity, primary care, children’s health insurance program, CHIP, fair drug pricing, Medicare Part D, generic drugs, biosimiliar, insulin, drug manufacturers, non-interference clause, COVID-19.
Creation Date
Modified Date
Pages
4
Document
acp_letter_to_house_sponsors_of_the_patient_protection_and_affordable_care_enhancement_act_hr_1425_june_2020.pdf
Adobe Metadata
{"Author":"Jonni McCrann","CreationDate":"2020-06-29T12:47:54-04:00","Creator":"Microsoft\u00ae Word 2016","Keywords":"Affordable Care Act, ACA, Patient Protection and Affordable Care Enhancement Act, HR 1425, health coverage, pre-existing conditions, prescription drugs, consumer protections, essential benefits, quality of care, coronavirus, COVID-19, health insurance marketplace, Medicaid, health insurance affordability fund, reinsurance, market stabilization, short-term limited duration health plans, FMAP, premiums, cost-sharing, mandatory work requirements, Medicaid pay parity, primary care, children\u2019s health insurance program, CHIP, fair drug pricing, Medicare Part D, generic drugs, biosimiliar, insulin, drug manufacturers, non-interference clause, COVID-19.","ModDate":"2020-06-29T13:41:31-04:00","Producer":"Microsoft\u00ae Word 2016","Title":"ACP Letter to House Sponsors of the Patient Protection and Affordable Care Enhancement Act (H.R. 1425)","Pages":4}
Document Type
Letter
Year
2020